![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Cleland Jennifer Thomas Mike Price David
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.4, Iss.3, 2003-03, pp. : 311-318
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease
By Jönsson L.
PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Time to give herbal medicines the pharmacoeconomics treatment
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 276, 2000-01 ,pp. :